Pancreatic Cancer Research

ResearcherKagoshima UniversityActive in the last 2 years

Shinichi Hashimoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1452-2374; OpenAlex author ID A5037144903, A5100230168. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 3 papers · 2024: none · 2025: none · 2026: 2 papers

Papers 10

  1. Establishment of simple pancreatic ductal adenocarcinoma identification method: S100P measurement in duodenal fluid obtained during upper gastrointestinal endo… Co-author DOI 10.1016/j.pan.2025.12.020↗
  2. Aldehyde Dehydrogenase 2 Activity Assessed Using the Acetaldehyde Breath Test Is Associated with Benign Pancreatic Disease and Pancreatic Cancer: A Case-Contro… Last author DOI 10.3390/jcm15197543↗
  3. Efficacy and safety of a novel anti-reflux metal stent during neoadjuvant chemotherapy for pancreatic cancer: A prospective multicenter exploratory study. First author DOI 10.1002/jhbp.1239↗
  4. Focal Type 2 Autoimmune Pancreatitis Mimicking Pancreatic Cancer: Treatment with Neoadjuvant Chemotherapy and Surgery. Co-author DOI 10.2169/internalmedicine.0224-22↗
  5. Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultrasound-Guided Fine-Needle Biopsy: A Prosp… Co-author DOI 10.3390/diagnostics13061078↗
  6. Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic ca… Co-author DOI 10.1002/dc.25022↗
  7. Value of Dual-Energy Computed Tomography for Detecting Small Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002207↗
  8. Trial protocol: a randomised controlled trial to verify the non-inferiority of a partially covered self-expandable metal stent to an uncovered self-expandable … Co-author DOI 10.1136/bmjopen-2020-045698↗
  9. Gemcitabine Plus Nanoparticle Albumin-bound Paclitaxel Versus FOLFIRINOX for Recurrent Pancreatic Cancer After Resection. Co-author DOI 10.21873/anticanres.15145↗
  10. Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000362↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takao Ohtsuka · 5 shared papers, 2022–2026 · strength 0.96
  2. Shiho Arima · 5 shared papers, 2021–2026 · strength 0.85
  3. Akio Ido · 5 shared papers, 2021–2023 · strength 0.76
  4. Makoto Hinokuchi · 4 shared papers, 2023–2026 · strength 0.75
  5. Michiyo Higashi · 4 shared papers, 2015–2023 · strength 0.52
  6. Akio Katanuma · 2 shared papers, 2021–2026 · strength 0.35
  7. Akihide Tanimoto · 2 shared papers, 2022–2023 · strength 0.30
  8. Hiromichi Iwaya · 2 shared papers, 2022–2023 · strength 0.30
  9. Yuko Mataki · 2 shared papers, 2015–2026 · strength 0.29
  10. Tetsuya Idichi · 1 shared paper, 2026 · strength 0.24
  11. Yusuke Kamikihara · 1 shared paper, 2026 · strength 0.24
  12. Kentaro Sudo · 1 shared paper, 2026 · strength 0.24
  13. Masafumi Nakamura · 1 shared paper, 2026 · strength 0.24
  14. Mamoru Takenaka · 1 shared paper, 2026 · strength 0.24
  15. Kazuo Hara · 1 shared paper, 2026 · strength 0.24
  16. Noboru Ideno · 1 shared paper, 2026 · strength 0.24
  17. Kenoki Ohuchida · 1 shared paper, 2026 · strength 0.24
  18. Yasuhisa Mori · 1 shared paper, 2026 · strength 0.24
  19. Keiji Hanada · 1 shared paper, 2026 · strength 0.24
  20. Masayuki Kitano · 1 shared paper, 2026 · strength 0.24
  21. Yoshihiko Fukukura · 2 shared papers, 2015–2022 · strength 0.19
  22. Seiya Yokoyama · 2 shared papers, 2015–2022 · strength 0.19
  23. Nobuhisa Maeda · 1 shared paper, 2023 · strength 0.18
  24. Yosuke Fujisaki · 1 shared paper, 2022 · strength 0.15
  25. Shinya Nakamura · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.